Fig. 1 · Structure
Documents & Downloads
Pegloxenatide
GLP-1R Agonist
Pegloxenatide is a long-acting glucagon-like peptide-1 receptor (GLP-1R) agonist. It exhibits various biological activities, including the reduction of blood glucose and lipids, weight management, anti-inflammatory effects, and promotion of wound healing, as well as providing protective effects on liver and heart tissues. Pegloxenatide is primarily utilized in research focused on type 2 diabetes and its associated complications.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Agonist |
| CAS Number | 2420483-82-3 |
| Applications | GLP-1R Agonist |
| Formula | (C₂H₄O)n(C₂H₄O)nC₂₀₆H₃₁₇N₅₅O₆₇S |
| Synonyms | Polyethylene glycol loxenatide; PEX 168 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.